» Authors » Milla Rosengard-Barlund

Milla Rosengard-Barlund

Explore the profile of Milla Rosengard-Barlund including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 29
Citations 1044
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Heinonen S, Saarinen T, Merilainen S, Sammalkorpi H, Penttila A, Koivikko M, et al.
Obesity (Silver Spring) . 2023 Nov; 31(12):2909-2923. PMID: 37987183
Objective: Although it has been suggested that one-anastomosis gastric bypass (OAGB) is metabolically superior to the "gold standard," i.e., Roux-en-Y gastric bypass (RYGB), there is little robust evidence to prove...
2.
Kostiainen I, Karppinen N, Simonen P, Rosengard-Barlund M, Linden R, Tarkkanen M, et al.
Endocrine . 2022 May; 77(1):177-187. PMID: 35536452
Purpose: Carcinoid heart disease (CHD) is a life-threatening complication of carcinoid syndrome (CS) characterised by tricuspid regurgitation (TR). However, there is an unmet need for earlier diagnosis of CHD. We...
3.
Kupila S, Venalainen M, Suojanen L, Rosengard-Barlund M, Ahola A, Elo L, et al.
JMIR Form Res . 2022 Mar; 6(3):e26374. PMID: 35262494
Background: As global obesity prevalence continues to increase, there is a need for accessible and affordable weight management interventions, such as web-based programs. Objective: This paper aims to assess the...
4.
Ashrafi R, Ahola A, Rosengard-Barlund M, Saarinen T, Heinonen S, Juuti A, et al.
Ann Med . 2021 Oct; 53(1):1885-1895. PMID: 34714211
Objectives: Our aim was to investigate in a real-life setting the use of machine learning for modelling the postprandial glucose concentrations in morbidly obese patients undergoing Roux-en-Y gastric bypass (RYGB)...
5.
Bernardi L, Gordin D, Bordino M, Rosengard-Barlund M, Sandelin A, Forsblom C, et al.
Sci Rep . 2017 Jul; 7(1):6001. PMID: 28729675
Hyperoxia and slow breathing acutely improve autonomic function in type-1 diabetes. However, their effects on arterial function may reveal different mechanisms, perhaps potentially useful. To test the effects of oxygen...
6.
Tikkanen-Dolenc H, Waden J, Forsblom C, Harjutsalo V, Thorn L, Saraheimo M, et al.
Diabetologia . 2016 Dec; 60(3):574-580. PMID: 28013340
Aims/hypothesis: Cardiovascular disease (CVD) is the most common cause of premature death and disability among patients with type 1 diabetes. Diabetic nephropathy accounts for the increased cardiovascular morbidity and mortality...
7.
Gordin D, Bernardi L, Rosengard-Barlund M, Makinen V, Soro-Paavonen A, Forsblom C, et al.
Acta Diabetol . 2015 Jul; 53(3):349-57. PMID: 26159114
Aims: Although oxygen is commonly used to treat various medical conditions, it has recently been shown to worsen vascular function (arterial stiffness) in healthy volunteers and even more in patients...
8.
Waden J, Tikkanen H, Forsblom C, Harjutsalo V, Thorn L, Saraheimo M, et al.
Diabetologia . 2015 Jan; 58(5):929-36. PMID: 25634228
Aims/hypothesis: The aim of this study was to assess how physical activity predicts the development and progression of diabetic nephropathy in patients with type 1 diabetes. Methods: This prospective study...
9.
Punkkinen J, Koskenpato J, Rosengard-Barlund M
Duodecim . 2014 Jul; 130(12):1223-33. PMID: 25016668
An autonomic disorder of the circulatory system becomes manifest as aberrant heart rate variability and baroreflex sensitivity already years before progressing into symptomatic disease, in which case the condition is...
10.
Bernardi L, Gordin D, Rosengard-Barlund M, Makinen V, Mereu R, DiToro A, et al.
Int J Cardiol . 2014 May; 175(1):169-71. PMID: 24856804
No abstract available.